Penserra Capital Management LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 75 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2021$330,000
-25.5%
537,236
+23.5%
0.01%
-22.2%
Q3 2021$443,000
-33.6%
434,874
+19.2%
0.01%
-25.0%
Q2 2021$667,000
+182.6%
364,964
+204.2%
0.01%
+200.0%
Q1 2021$236,000
+81.5%
119,988
+14.9%
0.00%
+33.3%
Q4 2020$130,000
-23.5%
104,408
+10.4%
0.00%
-50.0%
Q3 2020$170,000
-82.8%
94,608
-19.8%
0.01%
-88.2%
Q2 2020$989,000
+1.1%
117,992
-20.6%
0.05%
-23.9%
Q1 2020$978,000148,5420.07%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,738,925$23,555,00031.22%
Perceptive Advisors 1,232,500$7,764,0000.39%
IFP Advisors, Inc 1,001,025$6,306,0000.27%
WOODSTOCK CORP 55,489$350,0000.07%
Virtus ETF Advisers LLC 50,795$320,0000.05%
Dynamic Technology Lab Private Ltd 31,431$198,0000.04%
Evanson Asset Management, LLC 20,660$130,0000.03%
Artal Group S.A. 250,000$1,575,0000.03%
GSA CAPITAL PARTNERS LLP 58,800$370,0000.02%
Raymond James Financial Services Advisors, Inc. 426,280$2,686,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders